11 state treasurers call on Gilead to reduce remdesivir pricing

BY: LUCIEN BRUGGEMAN, ABC News(WASHINGTON) -- As the U.S. approaches 200,000 coronavirus deaths, a coalition of 11 state treasurers is calling on drugmaker Gilead Sciences to reduce the price of remdesivir, its promising treatment for some patients of COVID-19.